Free Radic Biol Med 15:667670 Chiechio S, Copani A, Nicoletti F, Gereau RW (2006) l-Acetylcarnitine: a proposed therapeutic agent for painful peripheral neuropathies
Within this context, Lillys meticulous R&D strategy and market execution have paid off: Mounjaro and ZepBound are generating record sales, and Lillys pipeline is deep with next-generation incretin candidates
Topline results from the twice-daily immediate-release formulation (announced December 2023) showed weight loss of approximately 813% over 32 weeks at higher doses, but with substantial discontinuation rates due to gastrointestinal side effects
Serious Potential Side Effects Being aware of potential side effects of tirzepatide allows you to be an active partner in your health journey
When you complete our assessment quiz, the data provided helps licensed healthcare professionals understand your unique health profile
Arthritis (both rheumatoid arthritis and osteoarthritis) and gout are two leading problems of bones and joints that affect a major segment of the population